These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 17270413)

  • 1. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
    Castaño Vidriales JL; Amores Antequera C
    Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
    Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
    Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
    Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
    Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions.
    Alexandrakis MG; Coulocheri SA; Bouros D; Eliopoulos GD
    Anticancer Res; 1999; 19(4C):3607-12. PubMed ID: 10629659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of acute phase proteins in pleural effusion discrimination.
    Calikoğlu M; Sezer C; Unlü A; Kanik A; Tamer L; Calikoğlu I
    Tuberk Toraks; 2004; 52(2):122-9. PubMed ID: 15241695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
    Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
    Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis.
    Garcia-Pachon E; Soler MJ; Padilla-Navas I; Romero V; Shum C
    Respiration; 2005; 72(5):486-9. PubMed ID: 16210887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
    Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
    Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of cytokine measurement in pleural effusion].
    Naito T; Ohtsuka M; Ishikawa H; Satoh H; Hasegawa S
    Kekkaku; 1997 Oct; 72(10):565-72. PubMed ID: 9386355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of c-c chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of C-C chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Pneumonol Alergol Pol; 2008; 76(6):415-20. PubMed ID: 19173189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions.
    Lin FC; Chen YC; Chen FJ; Chang SC
    Clin Immunol; 2005 Aug; 116(2):166-73. PubMed ID: 15897010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin -1beta (IL-1 beta), interleukin 6 (IL-6) and tumor necrosis factor (TNF) in plasma and pleural fluid of pneumonia, lung cancer and tuberculous pleuritis.
    Ilonidis G; Parapanisiou E; Anogeianaki A; Giavazis I; Theofilogiannakos EK; Tsekoura P; Kidonopoulou K; Trakatelli C; Polimenidis Z; Conti P; Anogianakis G
    J Biol Regul Homeost Agents; 2006; 20(1-2):41-6. PubMed ID: 18088554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.
    Chang SC; Hsu YT; Chen YC; Lin CY
    Arch Intern Med; 1994 May; 154(10):1097-101. PubMed ID: 8185423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adenosine deaminase activity in tuberculous and malignant pleural effusions].
    Safianowska A; Krenke R; Dmowska-Sobstyl B; Bogacka-Zatorska E; Domagała-Kulawik J; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):5-9. PubMed ID: 17175968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
    Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
    Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical investigation of the diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme in tuberculous pleurisy].
    Tian RX; Gao ZC
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):435-8. PubMed ID: 15312552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [VEGF (vascular endothelial growth factor) concentration in serum and pleural fluid of patients with pleural malignancy and pleural tuberculosis].
    Ziora D; Sielska-Spytek E; Dworniczak S; Oklek K; Kozielski J
    Pneumonol Alergol Pol; 2002; 70(9-10):458-67. PubMed ID: 12710098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.